Birdwatch Note Rating
2024-01-26 10:11:52 UTC - NOT_HELPFUL
Rated by Participant: F0BC97AEE18AD8B435FDDA9830C187CE90D83D2138934DD9AFE84FF06A119449
Participant Details
Original Note:
The new rule harmonizes the differences between HHS and FDA Human Subject regulations. It does not eliminate informed consent for trials with greater risk than minimal risks. Importantly, the rule allows for analyzing data/specimens collected during previous trials. https://www.federalregister.gov/documents/2023/12/21/2023-27935/institutional-review-board-waiver-or-alteration-of-informed-consent-for-minimal-risk-clinical
All Note Details